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Summary Heat shock protein (HSP) 47 is associated with collagen type I metabolism, both constitutively and after stress-inflicted injury. It
has been claimed that, in contrast to hyperthermia (HT), photodynamic therapy (PDT) does not damage collagen, as measured atthe level of
tissue. We have studied HSP47 expression in normal murine skin fibroblasts (3T6) treated with hyperthermia or photodynamictherapy (PDT)
mediated by three different photosensitizers: (1) haematoporphyrin ester (HpE), (2) meta tetra hydroxyphenyl chlorin (mTHPC) and (3)
riboflavin (RB). Riboflavin is not an established photosensitizer for PDT and was chosen here because it is known to provoke collagen
damage. The applied doses of the treatments were isoeffective in terms of 3T6 clonogenic cell survival. Analysis, at both transcriptional and
translational levels, revealed HSP47 elevation after hyperthermia and after PDT with RB. PDT sensitized by HpE and mTHPC did not
significantly alter HSP47 expression. These observations are consistent with our hypothesis that this collagen chaperone is up-regulated by
laser-mediated modalities known to damage collagen (i.e. HT and RB PDT) but not by more conventional PDT treatments. Additionally,
unexpected significant up-regulation of HSP47 was detected after illumination alone (no photosensitizer) of 3T6 cells at 653 nm laserlight, but
not at 630 nm.
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Photodynamic therapy (PDT) is an investigational cancer treat-
ment combining a photosensitive drug and its activation by non-
thermal laser illumination (Dougherty, 1992; Phillips, 1993/94).
Toxicity of PDT is believed to be mediated largely via reactive
oxygen species generated in a type II photochemical reaction
(Foote, 1991; van Hillegersberg etal, 1994). The low powerdensi-
ties of laser light are regarded as harmless to the tissue, in which
respect PDT differs from other laser applications in which
laser-tissue interactions cause pathological change (Thomsen,
1991). Laser hyperthermia, causing tissue necrosis by exposure to
temperatures in the range 42-45°C, shares one main advantage
with PDT: both treatments can be interstitially or endoscopically
delivered through fibreoptics to almost any organ of the body
(Masters and Bown, 1992). However, the treatments are believed
to act via separate mechanisms so that normal tissue damage
induced by laser hyperthermia and by non-thermal PDT might be
distinctively different (Gomer et al, 1988). Soft tissue is especially
prone to be affected as a result ofcollagen damage. One compara-
tive study of such damage and recovery processes, carried out on
rat colon (Barr and Bown, 1992), showed that mechanical para-
meters of PDT-treated colon were affected less and functional
recovery was complete, whereas an equivalent dose of hyper-
thermia caused more severe and permanent damage. Collagen
fibres ofheat-treated tissue were swollen and lost their periodicity
but PDT-treated tissue was unchanged. PDT has also been demon-
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strated to preserve the tensile strength of bladder and trachea
(Bown, 1990).
Heat shock protein HSP47, a 47-kDa glycoprotein known to be
elevated at 42°C and higher temperatures (Nagata et al, 1986), is
the only known stress response molecule able to bind collagen
(Nagata et al, 1988a, b). It is found in the endoplasmic reticulum
(ER) of cells producing collagen type I (Shroff et al, 1993) and is
actively involved in collagen type I biosynthesis (Natsume et al,
1994). It has been demonstrated by immunoprecipitation tech-
niques that HSP47 and procollagen form a complex in the ER.
This complex has been observed to co-precipitate in conditions
preventing collagen I heterotrimer formation (Nakai et al, 1992).
Involvement of HSP47 in the collagen metabolic path results in
changes of its expression after modulation ofcollagen I synthesis
rate under pathophysiological conditions in which synthesis of
collagen is either reduced (Takechi et al, 1992) or enhanced
(Masuda et al, 1994) and in the presence of toxins affecting
collagen metabolism (Sauk et al, 1990). Expression of HSP47 is
age-related and its up-regulation by heat exposure in older organ-
isms is reduced (Miyaishi et al, 1995).
PDT, as a treatment generating oxidative stress, might be
thought to stimulate a response resulting in elevation of stress
proteins. However, there are few studies examining this aspect of
the modality and the results vary. Heat shockprotein (HSP) 70 and
glucose-regulated protein (GRP) 78 were shown to be elevated
after PDT with haematoporphyrin derivative, with the level of
elevation depending on the type of experimental cell line (Gomer
et al, 1988). A second study, examining the same stress proteins
after PDT with chloroaluminium phthalocyanine in V79 Chinese
hamster fibroblasts, showed up-regulation of GRP78, but down-
regulation of HSP70 (Xue et al, 1995). A further study of stress
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response in the V79 cell line, after PDT with Photofrin, revealed
elevation of HSP70 and GRP75, -78 and -94 (Fisher et al, 1993).
Finally, application of PDT with benzoporphyrin derivative
effected an increase in expression of a number of stress proteins,
including HSP47 (Curry and Levy, 1993). In the present study,
we investigate HSP47 metabolism after comparable doses of
hyperthermia and PDT with three different photosensitizers: Two
well established [haematoporphyrin ester (HpE) and meta tetra
hydroxyphenyl chlorin (mTHPC)] and one unconventional for use
in PDT - riboflavin (RB). The choice ofRB was driven by reports
of collagen aggregation that was mediated by light exposure
in the presence of RB (Akiba et al, 1994; Kato et al, 1994).
Hyperthermia is known to cause extensive collagen damage. PDT,
as suggested by in vivo evidence, either is believed not to affect
collagen, or is followed by quick and efficient repair mechanisms.
Thus, the two other stresses applied in our study were PDT using
HpE and PDT using mTHPC.
MATERIALS AND METHODS
Cell culture
3T6 murine skin fibroblasts (Coriell Cell Repositories, NJ, USA)
between the third and 16th passages, were cultured in RPMI-1640
medium (Gibco BRL, Paisley, UK) supplemented with 10% fetal
calf serum (Gibco BRL) and antibiotics. A monolayer culture was
maintained in T75 flasks and subcloned weekly. For RNA and
protein extraction, cells were pregrown in 90-mm Petri dishes for
5-6 days in a humidified 5% carbon dioxide atmosphere at 37°C.
Cells were routinely tested for mycoplasma. Cell survival was
determined by performing clonogenic survival assays. To ensure
reproducibility, a feeder layer was prepared from the autologous
cell line by irradiation on a caesium source at a dose of 60 Gy.
Cells were plated to obtain a total cell density (feeder cells and
experimental cells) of 103 cells cm-2 (Cox and Masson, 1974).
Cells were allowed to grow for 10 days before staining with
gentian violet [10% (w/v) methyl violet 2B; Sigma, Poole, UK,
and 5% (v/v) formaldehyde in 70% ethanol; Prolabo, Manchester,
UK]. Colonies comprising more than 50 cells were scored as posi-
tive for clonogenic survival.
As a negative control for molecular studies, an HSP47 non-
expressing human leukaemia cell line (K562, Coriell) was main-
tained as a suspension culture in RPMI medium supplemented
with 10% horse serum (Gibco BRL).
Spectrophotometry
The light absorption characteristics of non-sensitized cells in the
range 400-700 nm were measured on a spectrophotometer
(Varian, Warrington, UK). Cells were washed with saline, scraped,
centrifuged and resuspended in saline to give a density of
2 x 106 cells ml-'. This cell density gave an optical density in the
cuvette of around 1.
Photosensitizers and light sources
Haematoporphyrin ester (HpE; Paisley Biochemicals, Glasgow,
UK), obtained dissolved in saline, was further diluted in saline to a
concentration of 100 jg ml-' and stored in aliquots at -20°C.
Throughout these experiments HpE was used in a final concentra-
tion of 5 ,ug ml-1 of medium. Meta tetra hydroxyphenyl chlorin
(mTHPC; Scotia Pharmaceuticals, Guildford, UK) was stored
refrigerated as a stock solution of 1 mg ml-1 in dimethyl
sulphoxide (DMSO) and for experiments was diluted in water and
used at a concentration of 0.2 jig ml-'. Riboflavin (RB, Sigma)
was stored refrigerated as a water solution of7.5 jg ml-1 and used
at a concentration of0.15 jg ml-'. The absorption spectrum ofRB
in the range of visible light was measured in both water solution
and in cells preincubated for 24 h with the drug. All photosensi-
tizers and photosensitizer-supplemented cells were carefully
handled to avoid light exposure. For HpE and mTHPC sensitiza-
tion (peak absorbances at 630 nm and 653 nm respectively), a
continuous-wave 20-W argon ion-pumped dye laser (Spectra
Physics, Hemel Hempstead, UK) was used. The power density of
the light at the cell surface was maintained at 20 mW cm-2. RB
was excited by a non-laser light source emitting continuous wave-
length from 400 to 700 nm, and was maintained at the cell surface
at 60 mW cm-2 (Whitehurst and Moore, 1995). Thesepowerdensi-
ties did not increase the temperature of the medium above
ambient.
Application of PDT and hyperthermia
In all PDT experiments, cells were preincubated for 24 h with a
sensitizer-supplemented medium plus serum. All experimental
plates were washed once with phosphate-buffered saline (PBS)
and the growth medium was replaced with fresh medium just
before application of the light treatment. Sensitivity of the 3T6
fibroblasts to the treatments was determined by a clonogenic
survival assay and, forthe molecular studies, applied atclonogenic
equitoxic doses defined as giving 60% cell survival, which were as
follows: 1.7 J cm-2 for HpE PDT; 1.5 J cm-2 for mTHPC PDT;
3 J cm-2 for RB PDT and 65 min incubation at 43°C for hyper-
thermia. The incubation for these in vitro experiments used a Mini
Oven Heraeus (DVE, Heraeus, Brentwood, UK). For each series
ofexperiments fourtypes ofcontrols were set: (1) untreated -cells
left in the tissue culture incubator; (2) 'low carbon dioxide' - cells
removed from the tissue culture incubator for the maximum dura-
tion of treatment; (3) 'light-only' - cells exposed to light in the
absence of drug; and (4) 'drug-only' - cells incubated with drug
but not illuminated.
Northern hybridization
The total cellular RNA was extracted at 0 (10 min), 3, 6 and 9 h
after the treatment application. Cells were washed with saline
before extraction using RNAzolB (Biogenesis, Poole, UK),
following themanufacturer's instruction with slight modifications:
RNA precipitation was carried out at -80°C for 16 h and the final
pellet was resuspended in diethyl pyrocarbonate (Sigma) treated
water and stored at -80°C. Extracted total RNA was quantified
using a Gene Quant II (Pharmacia Biotech, Herts, UK). RNA
(20jg perlane) was separated on 1.2% agarose formaldehyde gel,
with ethidium bromide present in the loaded sample and running
buffer, and transferred onto a nylon membrane (Hybond-N+,
Amersham, Little Chalfont, UK). The successfully transferred
RNA was visualized under UV light, and quantities of incorpo-
rated RNA on each lane measured as ethidium bromide fluores-
cence ofthe 18S and 28S ribosomal bands (Beere et al, 1993). The
filter was probed with a 1.5-kbEcoRI-HindIII fragment ofmurine
HSP47 cDNA (Takechi et al, 1992), which was received in
plasmid pUC19 as a generous gift from Professor K Nagata
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Figure 1 Results of analysis by Northern (A, C, E and G) and Westem hybridization (B, D, E and F) of HSP47 expression in 3T6 fibroblasts pretreated with:
hyperthermia A and B; HpE PDT, C and D; mTHPC PDT, E and F, and RB PDT, G and H. Values (means ± 1 s.e.) of HSP47 mRNA and protein expression
were calculated as a function of those of untreated controls and represented as 'X-fold the control value. Error bars represent inter-experimental variation
(n = 3-6 repeat experiments). 1, Low carbon dioxide control; O, hyperthermia; light-only control; I, drug-only control; *, PDT
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Table 1 Two-way analysis of variance of HSP47 expression (elevated 1 or
reduced .1), between hyperthermia (HT) and 'low CO2' control and between
PDT, 'light-alone' (L) or'drug alone' controls.
HT HpE mTHPC RB
Time (h) N W N W N W N W
0 PDTI1
P= 0.006
3
6 HT1 L.T PDTI
P= 0.003 P= 0.035 P= 0.0005
9 HT1 PDTT
P= 0.005 P= 0.009
12
Blank columns for HpE indicate that there were no significant differences at
any time. Occupied columns indicate that there were significant differences
(P< 0.05) between the variable shown and the other(s). Occupied cells show
the time at which differences were greatest for Northern (N) and Western (W)
hybridization analysis.
(Kyoto University, Japan). The probe was radiolabelled with
[a-32P]dCTP (Du Pont, Stevenage, UK), using an oligolabelling
method (Oligolabelling Kit, PharmaciaBiotech), and hybridized at
65'C overnight. The negative control was K562 RNA, which was
extracted using the same method. The incorporated radioactivity
was visualized by autoradiography and quantified on a GS-690
imaging densitometer (Bio-Rad, Hemel Hempstead, UK).
Western hybridization
Protein was extracted 3, 6, 9 and 12 h after the treatment applica-
tion. Before extraction cells were washed with PBS, then pelleted
and disrupted by sonication. K562 protein was used as the nega-
tive control. Protein concentration was determined by the method
of Bradford (1976). Protein was separated by 15% one-
dimensional sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis, according to the method of Laemmli (1970), along
with biotinylated broad-range SDS standards (Bio-Rad) and
transferred on Hybond-C+ membrane (Amersham). The
membrane was blocked with 5% bovine serum albumin (BSA) 5%
dry milk in PBS-Tween and incubated with anti-HSP47 poly-
clonal antibody, which was raised in rabbits against rat HSP47
(Stressgen, York, UK), followed by incubation with the secondary
anti-rabbit, peroxidase-linked antibody. The HSP47-antibody
complex was visualized by enhanced chemiluminescence using
Super Signal Substrate Western Blotting (Pierce, Rockford,
Illinois, USA) and quantitatively analysed on the GS-690 imaging
densitometer. The loading was normalized by the same procedure
against actin, using rabbit anti-actin antibody (Biogenesis). The
negative control, K562 protein, was used in all experiments.
RESULTS
The metabolism ofHSP47 in 3T6 fibroblasts varied after applica-
tion ofthe four different stress conditions. The stress factors were
of equivalent toxicity and the variations in HSP47 metabolism
were dependent on which stress condition was applied.
Hyperthermia caused an elevation ofHSP47 mRNA (Figure IA
and Table 1), and this was observed immediately after its applica-
tion. The maximum up-regulation was observed at the 6 h time
point. At the protein level (Figure 1B), the first up-regulation was
detected after 6 h and reached a maximum after 9 h. Lower,
although persistent, HSP47 elevation was also observed in 'low
carbon dioxide' controls at both transcriptional levels and transla-
tional levels (Figure IA and B).
No significant increase in either HSP47 mRNA (Figure IC) or
protein (Figure ID) was seen after PDT using HpE.
In 3T6 fibroblasts treated with mTHPC PDT, an absolute
increase but a relative decrease of HSP47 mRNA (Figure 1E) and
protein (Figure IF), was detected when compared with the 'drug-
only' and 'light-only' controls. The mTHPC alone appeared to
induce HSP47 transcription and translation. In addition, a large
increase in HSP47 mRNA and protein synthesis was demonstrated
after illumination of the cell in the absence of mTHPC, in which
the elevation reached its peak at transcriptional level immediately
after treatment, and at the protein level after 9 h.
PDT mediated by RB resulted in strong elevation of HSP47,
achieving a maximum at the RNA level after 6 h (Figure IG), and
at the protein level 9 h after treatment (Figure IH). The 'drug-
only' control showed slight up-regulation of HSP47, but this was
significant only for mRNA. Light-only (no RB) illumination
caused enhanced production ofHSP47 mRNA and protein 0 h and
6-9 h respectively after the illumination.
The absorption spectrum of3T6 fibroblast suspensions revealed
a strongly marked absorption peak at 656 nm. This observation
was not unique to the 3T6 cell line and was also confirmed on
other, randomly chosen murine and human fibroblast cell lines
(data not shown).
HSP47 elevation was induced by hyperthermia, PDT with RB
and light alone (no photosensitizer) illumination in the range
400-700 nm and 653 nm. PDT with HpE and PDT with mTHPC
did not have this effect and the latter resulted in a significant
relative decrease in HSP47 when compared with the elevated
values in the 'light-only' controls.
DISCUSSION
We have demonstrated that up-regulation of HSP47 by photo-
dynamic injury in 3T6 fibroblasts varies depending on the
light/photosensitizer combination. The 3T6 normal murine skin
fibroblast cell line is known to biosynthesize procollagen al(I)
and a2(I) chains, secrete them and deposit collagen type I, as seen
in extracellular matrix formation. The choice of 3T6 for the
purpose of this study enabled us to examine HSP47 in vitro in its
in vivo-like functional conditions. The constitutive HSP47 expres-
sion level (proportional to rate of collagen type I biosynthesis;
Natsume et al, 1994) is high in 3T6 cells. Our choice of 60% cell
survival for this initial experiment was driven by a compromise
between a reproducible degree of cell kill on the exponential
portion of the survival curve and obtaining enough cellular
material for analysis. The effects of a high extent of cell kill on
HSP47 await further study.
As it was originally detected as a heat shock protein, HSP47 has
been reported to be elevated by other factors and physiological
conditions (Natsume et al, 1994). All of the HSP47 up-regulation
factors described, including hyperthermia, either cause injury to
collagen matrix or affect its biosynthesis.
Studies of stress response after PDT are still at an early stage,
but inspection of the literature suggests that this aspect of PDT
may be complex and heterogeneous. Gomer et al (1988) studied
expression of three stress proteins after PDT with porphyrin
British Journal ofCancer (1997) 76(6), 719-724 0 Cancer Research Campaign 1997HSP47andphotodynamic therapy 723
derivatives. GRP78, HSP70 and a 34-kDa protein showed
different kinetics, which varied for each of the proteins between
smooth muscle, fibroblasts and endothelial cells. Expression of
HSP70 was also reported to be increased by Photofrin II-mediated
PDT (Fisher et al, 1993), and diminished by aluminium phthalo-
cyanine-mediated PDT (Xue et al, 1995). The experiments
showing these two different effects were performed on the same
Chinese hamster V79 cell line. Curry and Levy (1993) monitored
expression of stress response proteins after PDT, using benzo-
porphyrin derivative in MI murine tumour (rhabdomyosarcoma)
cells, up to 24 h after treatment. Overtime, they detected an eleva-
tion of a wide range ofproteins, including HSP47. The PDT dose
applied for the experiment showing diminished expression of
HSP70 resulted in severe morphological changes ofMI cells. The
treatment described would probably beharsh enough to disturb the
extracellular matrix metabolism, which in a tumourcell line would
not necessarily be as stable as in normal cells.
Elevation ofHSP47 by hyperthermia on both transcriptional and
translational levels has been well studied previously (Nagata et al,
1986), therefore the results obtained here met ourexpectations and
confirmed the applicability of the chosen methods. The detected
HSP47 up-regulation in 'low-carbon dioxide' controls was prob-
ably induced by change in pH of the medium due to removal of
experimental plates from carbon dioxide-enriched tissue culture
incubator atmosphere.
The lackofelevation ofHSP47 expression after PDTusing HpE
or even its down-regulation relative to the controls after mTHPC
PDT would be consistent with an absence of damage to collagen,
although that inference awaits confirmation by on-going studies of
collagen type I and its precursor molecules. There is one report
presenting evidence for extensive collagen aggregation by 102
generated in an HpE-sensitized reaction (Kakehashi et al, 1993).
These studies were carried out on collagen in a solution containing
HpE at a concentration calculated to be 60 ,ug ml-', which is over
tenfold greaterthatthe oneusedby us, and also higher than in clin-
ical applications (Dougherty and Marcus, 1992). Additionally a
cell-free environment, unlike a physiological one, lacks factors
important for the modulation of active oxygen species, e.g.
quenchers ofsinglet oxygen or superoxide. Curry and Levy (1993)
observed HSP47 up-regulation, together with many other stress
proteins, using a new PDT sensitizer benzoporphyrin derivative.
Their study differed from ours in that (1) the dose they applied
reduced cell viability to 30% (6 h after the treatment) and (2)
they examined tumour rather than normal cells. We cannot at
present rule out that changes in HSP47 simply represent part of a
generalized stress response, but if so it is expressed differentially
between modalities whose initial 'stress' (in terms ofcytotoxicity)
was the same.
Where a photosensitizer-light combination is known to damage
collagen, e.g. riboflavin plus visible light (Akiba et al, 1994), we
observed marked transcriptional and translational up-regulation.
Interestingly, a strong increase in HSP47 expression rate was also
manifested after illumination by non-laser light alone at the range
400-700 nm and laser wavelength 653 nm. The effect was rapid
and was observed immediately after the exposure at the RNA
level, whereas the transcriptional up-regulation by PDT with RB
and hyperthermia was observed later, i.e. after 3-6 h. The illumi-
nation-alone HSP47 elevation is not understood, however our
preliminary studies of the 3T6 absorption spectrum (data not
shown) suggest the presence of a discrete chromophore with
The molecular events after PDT, in particular, are likely to be
complex as at least three 'stresses' may be present: it has been
claimed that low levels of light alone have physiological effects
(Baxter et al, 1994; Cambier et al, 1996); porphyrins have variable
toxicities (Juknatt et al, 1995; Haylett et al, 1996) and PDT is an
oxidative stress. The overall outcome includes the possibility of a
net down-regulation relative to 'controls' (mTHPC in this paper;
Xue et al, 1995).
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